UroGen Pharma (URGN) PT Lowered to $75 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju lowered the price target on UroGen Pharma (NASDAQ: URGN) to $75.00 (from $82.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
